serves as Senior Director, Global Health Economics and Outcomes Research, at Beckman Coulter. Mark received his PhD degree in Pharmaceutical Chemistry from UCSF, and post-doctoral training in molecular biology from the University of Maryland. He has over 30 years of R&D leadership experience in the clinical diagnostics industry, with tenures at Biosite(Alere), Gen-Probe(Hologic), and Iris Intl. (Beckman Coulter) prior to joining Danaher. He currently leads Health Economic and Outcomes Research for Danaher’s Global Market Access Team.